BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15722241)

  • 1. Use of intragastric pH monitoring in gastroesophageal reflux disease.
    Katz PO
    Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):277-87. PubMed ID: 15722241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CON: Treatment with PPIs should not be preceded by pH monitoring in patients suspected of laryngeal reflux.
    Vaezi MF
    Am J Gastroenterol; 2006 Jan; 101(1):8-10. PubMed ID: 16405526
    [No Abstract]   [Full Text] [Related]  

  • 3. Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease.
    Katz PO
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():3-11. PubMed ID: 16483265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
    Milkes D; Gerson LB; Triadafilopoulos G
    Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRO: Empiric treatment with PPIs is not appropriate without testing.
    Belafsky PC
    Am J Gastroenterol; 2006 Jan; 101(1):6-8. PubMed ID: 16405525
    [No Abstract]   [Full Text] [Related]  

  • 6. A BALANCING VIEW: Empiric PPI therapy remains the champ, but not by a knock out!
    DeVault K
    Am J Gastroenterol; 2006 Jan; 101(1):10-1. PubMed ID: 16405527
    [No Abstract]   [Full Text] [Related]  

  • 7. Catheter-based pH monitoring: use in evaluation of gastroesophageal reflux disease symptoms (on and off therapy).
    DeVault KR
    Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):289-306. PubMed ID: 15722242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory intragastric pH monitoring: clinical laboratory to clinical practice.
    Katz PO
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S3-9. PubMed ID: 14671508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current medical management of gastroesophageal reflux disease.
    Locke GR
    Thorac Surg Clin; 2005 Aug; 15(3):369-75. PubMed ID: 16104127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for gastroesophageal reflux disease: more is not necessarily better.
    Metz DC
    Am J Gastroenterol; 2003 Sep; 98(9):1913-5. PubMed ID: 14499765
    [No Abstract]   [Full Text] [Related]  

  • 11. Noncardiac chest pain and proton pump inhibitors.
    Bobba RK; Arsura EL
    Arch Intern Med; 2006 Jan; 166(2):248; author reply 248-9. PubMed ID: 16432099
    [No Abstract]   [Full Text] [Related]  

  • 12. Review article: gastric pH -- the most relevant predictor of benefit in reflux disease?
    Armstrong D
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():19-26; discussion 38-9. PubMed ID: 15456460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing medical therapy for gastroesophageal reflux disease: state of the art.
    Katz PO
    Rev Gastroenterol Disord; 2003; 3(2):59-69. PubMed ID: 12776003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Con: Impedance-pH testing does not commonly alter management of GERD.
    Richter JE
    Am J Gastroenterol; 2009 Nov; 104(11):2667-9. PubMed ID: 19888231
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro: Impedance testing is useful in the management of GERD.
    Blondeau K; Tack J
    Am J Gastroenterol; 2009 Nov; 104(11):2664-6. PubMed ID: 19888230
    [No Abstract]   [Full Text] [Related]  

  • 18. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
    Hirano I
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid-related disorders and use of antisecretory medication.
    Lassen AT
    Dan Med Bull; 2007 Feb; 54(1):18-30. PubMed ID: 17349216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.